Yuyu Pharma, Inc. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported negative sales was KRW 0.00002 million compared to KRW 0.00003 million a year ago. Net loss was KRW 293.15 million compared to net income of KRW 277.3 million a year ago.

Basic loss per share from continuing operations was KRW 22 compared to basic earnings per share from continuing operations of KRW 13.5 a year ago. Diluted loss per share from continuing operations was KRW 22 compared to diluted earnings per share from continuing operations of KRW 13.5 a year ago. Basic loss per share was KRW 22 compared to basic earnings per share of KRW 27 a year ago.